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The aim of the present work was to estimate the effect of 
intracellular glutathione depletion on melanogenesis in 
human melanoma cells. We determined tyrosine hydroHla-
tion activity, the rate-limiting step of the pathway, and 
14C-Ulelanin formation, an assay reflecting the global eume-
lanogenic pathway. Intracellular glutathione was depleted by 
treatUlent with buthionine-S-sulfoximine, a well-known in-
hibitor of y- glutamylcysteine synthetase. . 
The intracellular depletion of glutathione was substantial 
after 20 h of incubation with 50 pM buthionine-S-sulfoxi-
mine, although a significant effect could be observed after 
6 h. Tyrosine hydroxylase activity increased in parallel with 
glutathione depletion, to reach 160% with respect to the 
control values during 24 h of buthionine-S-sulfoximine 
treatrnent_ We have found the response to buthionine-S-sul-
T he biosynthesis of melanin, the main pigment found in mammalian skin, hair, ears, and eyes, proceeds through a complex serie.s of enzymatic and che~ical reactions [1]. The melanms produced are conventIOn-ally classified into two major types: eumelanins 
(brown or black) and sulfur-containing (red or yellow) pheomela-
nins. Tyrosinase is the key enzyme of the first part of the melano-
genesis path way, catalyzing the conversion of L-tyrosine into L-do-
paquinone. This latter o-quinone may subsequently be convert~d to 
L-dopachrome, which is a eumelanin intermediate, or alternatively 
may react non-enzymatically with cysteine or glutathione (GSH) to 
fonn the sulfur-containing pheomelanins. 
Intramelanocytic GSH is involved in the regulation of melano-
genesis in at least two ways: first, by its possible interaction with the 
tyrosinase-active site [2,3], and second, by the reaction of its thiol 
group -with L-dopaquinone, which may lead to sulphydryl-dopa 
conjugates and hence the sulfur-containing pheomelanins, instead 
of eumelanins [2,4,5J. 
One of the most well-known signals for increased pigment pro-
duction in human skin is ultraviolet radiation (UVR), although the 
mechanisms ofUVR action remain unknown. Chakraborty et at [6] 
reported that UV light acts indirectly, increasing the number of 
melanocyte-stimulating hormone (MSH) binding sites on the cell 
membrane, but Friedmann and Gilchrest [7] showed that UVR can 
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foximine to be dose dependent and the two different human 
cell lines HBL and LND1 to have similar, if not identical, 
responses. 14C-melanin formation assay revealed even greater 
activation, up to 400% of the control values. This indicates 
that glutathione depletion may have two distinct effects: 
first, a direct one on tyrosinase activity and, second, an effect 
on the promotion of eumelanogenesis. The stimulation of 
tyrosine hydroxylase can be explained by a possible inactiva-
tion of the enzyme by endogenous thiol compounds rather 
than by a direct effect ofbuthionine-S-sulfoximine itself on 
tyrosinase. The data suggest that thiol compounds may playa 
role for stimulation of melanogenesis by ultraviolet radia-
tion. Key words: glutathione/tyrosinase/melanogenesis. 
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stimulate melanogenesis in the absence of added MSH. Although 
MSH could be produced endogenously by me1anocytes [8], other 
mediators could also be involved in the cell melanogenic response to 
UVR. One plausible mediator might be GSH because it is well 
known that UVR increases extra- and intracellular generation of 
oxygen radicals, and GSH would react with these radicals and 
would protect epidermal cells from the cytotoxic effects [9-11] of 
reactive oxygen. 
Buthionine-S-sulfoximine (BSO) inhibits intracellular GSH syn-
thesis [12,13] and has been widely used for depleting intracellular 
GSH, allowing for the investigation of the role of GSH in more 
detail. The aim of this study was to examine the role of GSH as a 
modulator of the melanogenesis pathway in human melanoma cells, 
particularly its specific effects on tyrosine hydroxylase activity and 
on melanin formation. 
MATERIALS AND METHODS 
Reagents Radioactive L-[3,5-3HJ-tyrosine (specific activity 47 Ci/mmol) 
and L-(14CJ-tyrosine (specific activity, 479 mCi/mU1ol) were obtained from 
Amersham (U.K.). BSO, GSH, and 5,5' -dithiobis-(2-nitrobenzoic acid) 
(DTNB) were pu.rchased from Janssen Chimica (Belgium). Nicotinamide 
adenine dinucleotide (NADPH) tetrasodium salt and yeast glutathione re-
ductase (120 U/ ml) were purchased from 130ehringer Mannheim (Ger-
many). L-tyrosine, trichloroacetic acid, HCI, Norit A, Celit 535, and eth-
ylenediamine tetraacetic acid (EDTA) were obtained from Merck 
(Germany) and 3,4 dihydroxyphenylalanine (L-dopa) and Nonidet P40 
were from Sigma Chemical Co (St. Louis, MO). Culrure media and supple-
ments were purchased from Gibco (U.K.). 
Cells HBL and LNDl are human cell lines established in our laboratory 
and cultured in Ham's FlO medium containing 10% fetal calf serum, 1 % of a 
penicillin-streptomycin solution containing 10,000 U / ml-l 0,000 fig/ml, 
1 % of kanamycin (1,000 fig/ml), and 1 % glutamine (200 mM) (14J. 
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Cells were seeded at 6 X 106 cells per 175-cm2 flask. After 24 h culture, 
1 - 50 JIM BSO was added to the medium for various times and cells were 
harvested by trypsin-EDTA treatment. In all treatments, cell viability was 
higher than 90%. A triplicate set of flasks was used for every experiment. 
Tyrosinase was extracted from 8.5 X 106 cells in 1 ml Hanks' balanced salt 
solution after homogenization and sonication. Crude extracts were divided 
into two lots: one left as such for protein determination (Lowry et al [15]) and 
eumelanin formation as described below and the other treated with Nonidet 
P40 at 1% final concentration and centrifuged at 10,000 Xg for 10 min. 
Tyrosine hydroxylase activity and GSH concentration were measured in the 
supernatants as described below. 
In some experiments, HBL cells were solubilized in Hank's balanced sa lt 
solution containing 1 % Nonidet P40 and suspended at 4 X 106 cells/ml. 
The preparation was ultracentrifuged at 105,000 X $ for 30 min in a TL-
100 Beckman ultracentrifuge to remove non-solubIlized matenal. The su-
pernatant was divided into 2-ml aliquots and incubated with 10, 2, or 0 mM 
freshly prepared GSH in 10 mM phosphate buffer, pH 6.8, COnta111111g 0.1 % 
Nonidet P40 for 15 min. Each aliquot was dialyzed twice at 4 · C during 3 h 
against 500 ml of the same buffer. After 3 h the dialysis buffer was changed 
to remove GSH excess. Tyrosine hydroxylase activity was measured imme-
diately after dialysis. The experiment was repeated twice. 
Tyrosine Hydroxylase Assay and Melanin Formation Assay Incuba-
tions were performed as described by Hearing and Ekel [16], as modified by 
Jara et at [17]. 
Briefly, tyrosine hydroxylase was conducted as follows: 30 JlI cell extract 
were added to 10 Jll of 0.25 mM L-tyrosine (final concentration) containing 
0.0204 mM tritiated L-tyrosine (specific activity 49 Ci/mmol) and 10 Jll of 
a solution containing chloramphenicol (1 mg/ml), penicillin G (1000 
units/ml), bovine serum albumin (0.1 mg/ml), and 0.05 mM L-dopa (the 
cofactor), in a final volume of 50 JlI. Antibiotics were included to inhibit any 
protein synthesis and/or incorporation of radioactive tyrosine into macro-
molecules other than melanin. All solutions were prepared in 10 mM phos-
phate buffer, pH 6.8. The assays were run in triplicates in Eppendorf tubes at 
37"C for 1 h. After incubation, 50 mg Norit A, 50 mg Celit 535 and 450 Jll 
of 1 % trichloroacetic acid were added. Tubes were shaken for 30 min and 
centrifuged at 13000 X g. Supernatant (100 Jll) was removed and counted 
for radioactivity in a fJ counter. One unit of tyrosine hydroxylase was defined 
as the amount of enzyme that catalyzes the hydroxylation of 1 Jlmol L-tyro-
sine/min. 
Thirty microliters of crude extract were used to measure melanin forma-
tion. Incubations were performed at 37 ° C in micro titer plates for 1 h as for 
tyrosine hydroxylase (same substrate and same cofactor fina l concentra-
tions), but 14C-tyrosine was used as the radioactive substrate at the concen-
tration of 0.106 mM (specific activity 479 mCi/mmol). The reaction was 
stopped by the addition of 150 Jll of a solution containing 6% trichloroacetic 
acid and 10 mM unlabeled tyrosine. Thesamples were passed through fiber-
glass filters and the filters were washed three times with 150 Jll 0.1 mM 
HCI, dried, and counted. Blanks were subtracted from experimental samples 
to obtain net cpm. One unit of tyrosinase was considered as the amount of 
enzyme able to catalyze the incorporation of 1 Jlmol L-tyrosine into eume-
lanin (acid insoluble)/min, as described by Hearing and Ekel [16]. 
GSH Determination Total intracellular GSH was measured in cell ex-
tract containing 1% Nonidet P40 following the method of Griffith [18]. 
This assay is based on the reduction of the aromatic DTNB to chromogenic 
thio-nitrobenzoic acid (TNB) by GSH, which is oxidized to the disulfide 
form (GSSG). Total GSSG was then reduced back to GSH by glutathione 
reductase and NADPH. Routinely, SO Jll of cell extracts were diluted to 
200 Jll with phosphate buffer (10 mM, pH 7.5; 6.3 mM EDTA) , and mixed 
with 100 Jll of a 6 mM DTNB solution and 700 Jll ofNADPH (0.3 mM in 
phosphate buffer, pH 7.5; 10 mM, 6.3 mM EDTA) at 25 °C. After the 
sample reached a stable absorbance value, ~he reaction .was started with 10 Jll 
of a 20-U /ml glutathione reductase solutIOn and the 111crease 111 absorbance 
was monitored at 412 nm. Two nmol of GSH per ml measured by tillS 
method corresponds approximately to 1 mM intracellular GSH concentra-
tion. 
RESULTS 
Fourteen experiments showed that treatment ofHBL human mela-
noma cells with 50 J.lM BSO for 24 h increased tyIOsine hydroxyl-
ase activity . Statistical analysis of these experiments revealed an 
increase of approximately 158% in tyrosine hydroxylase activ-
ity (control, 0 .863 ± 0.315; BSO treated, 1.36 ± 0 .50 mU/ 
mg, 0 .001 < P < 0 .01), and a significantly higher increase in 
14C-melanin formation of about 400% (control, 30.9 ± 20.8 J.lU/ 
mg; BSO treated, 122.4 ± 81.5 J.lU/mg, p < 0 .001). The BSO-in-
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Figure 1. Effect of BSO on tyrosine hydroxylase. HBL (empty bars) and 
LNDl (dashed bars) human melanoma cells were exposed to SO JIM BSO for 
24 h. Enzyme activity was measured according to Jara et at [17]. Control 
values were calcu lated as mean ± SD (n = 3): 0.675 ± 0.109 mU /mg for 
HBL and 0.864 ± 0.013 mU/mg for LND1. This assay has been repeated 
twice on each cell line with similar results. 
duced increase of tyrosine hydroxylase activity was concentration 
dependent and very similar in two different human melanoma cell 
lines, HBL and LNDl (Fig 1). Therefore, all subsequent following 
experiments were performed using HBL cel ls. 
Figure 2 illustrates the time-course change in GSH intracel-
lular concentration, tyrosine hydroxylase activity (Fig 2a), and 
14C-melanin formation (Fig 2b) after cell exposure to 50 J.lM BSQ. 
GSH concentration fell 3 h after the beginning of the incubation 
and reached the lowest values at 20 h after treatment. Tyrosine 
hydroxylase activity increased rapidly between 6 and 12 h (Fig 2a). 
14C-melanin formation increased with time for at least 48 h 
(Fig 2b). 
When cell extracts were incubated for 15 Inin with this thiol 
compound and then extensively dialyzed to remove excess free 
GSH, a concentration-dependent decrease in enzyme activity of 
27% or 88% for 2 or 10 mM GSH, respectively, was observed (Fig 
3). The results support the hypothesis that GSH inactivates tyro-
sinase. . 
To test the possibility that the effect ofBSO on tyrosinase activity 
is mediated by GSH depletion, HBL cells were exposed to 10 mM 
exogenous GSH with or without 50 J.lM BSO (Fig 4a). Both tyro-
sine hydroxylase activity and '4C-melanin formation were de-
creased after incubation with GSH alone (0.001 < P < 0.01 and 
p < 0.001, respectively). However, the combined GSH plus BSO 
treatment also provoked a decrease of tyrosine hydroxylase very 
similar to when GSH alone was applied (about 40% with respect to 
untreated cells, 0.001 < P < 0.01) . In contrast, the combined effect 
ofBSO plus GSH enhanced '4C-melanin formation twofold, com-
pared with untreated cells. Furthermore, intracellular GSH in-
creased after incubation with exogenous GSH alone, but it was 
depleted by BSO irrespective of the presence or absence of exoge-
nous GSH (Fig 4b). 
DISCUSSION 
In our experiments, as previously reported [19,20], BSO treatment 
induced GSH depletion in human melanoma cells . When 50 J.lM 
BSO was added to the culture m edia, intracellular GSH content 
reached a minimum level after 20 h of exposure in HBL cells (Fig 
2a), a period similar to that reported by Karg et al [19] on IGRI 
human melanoma cells. This suggests a greater resistance to GSH 
depletion in human melanoma cells compared to mouse melanoma 
cells, ill which 25 J.lM BSO and only 4 h incubation were enough to 
substantially deplete intracellular GSH [21]. 
It is well documented that melanogenesis is affected by thio! 
compounds [2 -4,22 -26] . This effect is caused by at least two dif-
ferent mechanisms. First, low -molecular-weight thio! compounds 
can inhibit melanogenesis by direct interaction of thiol groups with 
the tyrosinase active site [2,3]' thus inhibiting tyrosine hydroxyla-
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Figure 2. (a) Time course of GSH content and tyrosine hydroxylase activo 
ity (percent of control) in HBL human melanoma cells treated with 50 f.lM 
BSO. GSH (0) was measured according to Griffith (18). and tyrosine hy· 
droxylase (0) was measured according to Jara et al (17) . The results are 
expressed in percent of control. Control values: GSH. mean, 168 nmol/ mg 
(range: 170 - 166 nmol/mg) (n = 2); tyrosine hydroxylase, 1.21 ± 0.02 
roV /mg (mean ± SO; n = 3). The experiment was performed rwice with 
similar results. (b) Time course of I'C-melanin formation activity. The 
activity 'Was measured according to Jara et al (17). Other conditions are 
presented in (a). Control , 41.4 ± 3.2 f.lU / mg (mean ± SO; n = 3). This 
experiment was performed rwice with simila.r results. 
tion. Second, thiol groups are able to react with L-dopaquinone to 
form dopa-thiol cOI~ugates [1] , which are pheomelanogenic pre-
cursors. The slower rate of the chemical reactions involved in the 
polymerization of these intermediates and their higher solubility 
127] in comparison to that of indols in the eumelanin pathway leads 
to an apparent inhibition of melanin synth esis, as measured by the 
He -melanin formation assay [2]. 
Our studies show that BSO treatment promotes the activation of 
tyrosinase activity in human melanoma cells. This increase might be 
explained e ither by a direct activation of the enzyme or by the 
removal of some endogenous inhibitor. Direct activation of the 
enzyme is unlikely, as we have observed that BSO had no effect on 
purified tyrosine hydroxylase activity in vitro (data not shown). Ac-
cordingly , the effect of BSO on tyrosine hydroxylase activity must 
be related to the concomitant GSH depletion (Fig 2a). 
Recently, J ergil et al [3] indicated that thiol compounds inacti-
vated tyrosinase. In agreement with their findings, we found that 
the decrease in enzyme activity induced by incubation with GSH 
was not recovered by extensive dialysis (Fig.3) . The concentration-
dependent inactivation of tyrosinase by GSH may be caused by 
interaction w ith the copper ion in such a way that GSH could not 
easily be displaced from the active site of the enzyme. 
Considering these results and the normal GSH concentrations in 
human m.elanoma cells (1-10 rnM), we conclude that the tyrosin-
ase pool may be partially inactivated by endogenous GSH. Thus, a 
significant part of the increased BSO induced in enzymatic activity 
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Figu~e 3. ~ecovery of tyrosine hydroxylase activity (percent of control) 
after I11cubatlol1 wltb GSH and dialys is. HBL cell extracts were preincubated 
for 15 nun WIth GSH (2 and 10 mM) and then dialyzed as described in 
Materials o"d Methods. Control value, 0.687 ± 0.048 mU/mg. The experi-
ment was repeated rwice with different HBL cell extracts, and the presented 
results arc the mean ± SO from both experiments (n = 4). 
would come from de 110110 synthesis of tyrosinase molecules. The low 
GSH levels measured in BSO-treated cells may prevent the inacti-
vatlon of the newly synthesized tyrosinase in those treated cells. 
The reported half-li fe of tyrosinase in mammalian melanocytes, 
around 8 -10 h [28,29], agrees with the time needed by BSO treat-
ment to increase the tyrosine hydroxylase activity. 
As discussed above, the higher rate in 14C-melanin formation 
compared to the increase in tyrosine hydroxylase results from the 
effect of GSH depletion not only 011 tyrosinase, but on the w hole 
pathway. Under physiologic conditions, intracellular GSH levels as 
well as other thiol compounds should be high enough to favor 
pheomelanogenesis so that cysteinyl-dopa (the major pheomelanin 
precursor) is directly [4] or indirectly formed from glutathionyl-
dopa hydrolysis [26] . Following intracellular GSH depletion, tyro-
s1l1e l~ydroxy l ation was enhanced, suggesting that melanogenesis 
flow 1I1creases along with L-dopaquinone formation . On the other 
ha.nd, the ability of L-dopaquinone to react with thiol and yield 
tluol-dopa conjugates is slower under conditions of GSH depletion. 
The final result should be that L-dopachrome and hence eumelano-
genesis are increased. 11'1 lIivo this mechanism may be autocatalytic, 
because dopa is generated in the eumelanin pathway by spontaneous 
reaction between dopaquinone and cyclodopa [1 ,17]. This dopa 
could act as cofactor for tyrosinase and thereby activate tyrosine 
hydroxylation. 
Intracellular BSO-induced GSH depletion was expected to be 
reversed by adding exogenous GSH to the cell culture medium. 
When GSH was added alone, intracellular GSH increased. but more 
interestingly, when BSO and GSH were added together, intracellu-
lar GSH remained vety low and very similar to the GSH content 
found in cells treated with BSO alone (Fig 4b) . T hese data are in 
agreement with the proposal by Meister et af [11,12], who postu-
lated that exogenous GSH cannot be taken up by mammalian cells, 
but ~ust be spliced by the membrane-bound transpeptidase. There-
f~r:, 111 the presence of BSO, y-glutamyl-cysteine synthetase is in-
hibited and subsequently prevents GSH synthesis. However, the 
cytosolic concentrations of GSH precursors, such as cysteine, wou ld 
be greater than in untreated cells [4] . This same cysteine may be 
responsible for preventing an increase in tyrosine hydroxylase w hen 
both GSH and BSO are present, as it is a tyrosinase-inactivating 
agent and has more affinity for the enzyme catalytic site than does 
GSH [3]. 
Although tyrosine hydroxylase activity was actually decreased, 
treatment BSO plus GSH increased 14C-melanin formation. How-
ever, the increase was lower than the one provoked by BSO alone 
(Fig 4a). This apparent discrepancy between tyrosine hydroxylase 
and 14C-melanin formation data can be partially explained by the 
action of thiol compounds on the pheo/eumelanogenesis switch 
discussed above. In addition, 14C-me lanin assay reflects the global 
eumelanogenesis pathway, in which other melanogenic enzymes 
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Figure 4. (a) Tyrosine hydroxylase activiry (empty bars) and I4C-melarun 
formation (dashed bars) in HBL cells treated with GSH (10 mM) and BSC 
(50 11M) for 24 h. Control values (mean ± SD; n = 3): 1.07 ± 0.04 mU/ 
mg (ryrosine hydroxylase) and 47.0 ± 1.9l1U/mg (14C-melanin assay). (b) 
Intracellular GSH content of HBL cells. Cultures were treated as described 
in (a). Control mean: 210 nmol/mg (range: 208-212, n = 2). This experi-
ment was performed twice with similar results. 
different from tyrosinase [29], such as TRP-l and TRP-2, could also 
play important roles in the modulation of this assay [16]. In agree-
ment with this possibility, we recently reported that BSO increases 
TRP-2 activity in B16 mouse melanoma cells [21], and the same 
enzyme has been shown to accelerate 14C-melanin formation 
[30]. Taking all these considerations together, we conclude that 
14C-melanin formation may be enhanced even when tyrosine hy-
droxylase is inhibited. 
Although it is well known that UVR induces melanogenesis, it is 
not clear whether melanocytes are stimulated either directly by 
UVR or indirectly by other factors produced in the skin that medi-
ate the UVR action. The role of a -MSH and cyclic adenosine mon-
ophophate (cAMP) in the process is under discussion [6,7], but other 
possible intracellular mediators whose concentrations can be af-
fected by UVR could be involved. GSH plays a major role in pro-
tecting human skin from the free-radical damage induced by UVR 
[10]' and the drop in the intramelanocytic GSH induced by UVR 
might be an inducer of the cellular pigment response. Our data 
suggest that GSH depletion increases tyrosinase activities and favors 
eumelanogenesis (versus pheomelanogenesis). Further studies are 
needed to elucidate the influence of UVR on the concentration of 
GSH in melanocytes. 
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